A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by Propensity Score analysis.

Adalimumab and golimumab are effective in the treatment of moderate to severe ulcerative colitis.

Source: Digestive and Liver Disease - June 21, 2018 Category: Gastroenterology Authors: Sara Renna, Filippo Mocciaro, Marco Ventimiglia, Rosalba Orlando, Fabio Salvatore Macaluso, Maria Cappello, Walter Fries, Marco Mendolaro, Antonino Carlo Privitera, Concetta Ferracane, Valentina Pisana, Antonio Magnano, Dario Pluchino, Gaetano Inserra, Gi Tags: Alimentary Tract Source Type: research